Expanded Access Study for Renal Transplant Patients With Envarsus XR: Envarsus 3007

Trial Profile

Expanded Access Study for Renal Transplant Patients With Envarsus XR: Envarsus 3007

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 Jan 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Expanded access; Therapeutic Use
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 29 May 2015 Status changed from not stated to unconfirmed.
    • 13 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top